Key result
Hyperkalemia-related sudden cardiac death mortality rose ~5% annually from 2010 to 2020.
Why the study?
National trends in hyperkalemia-related sudden cardiac death remain poorly defined, especially in the aging US population.
Cross-Sectional (n=36,607)
Yes
Hyperkalemia-related sudden cardiac death mortality has doubled in the United States over the past two decades, with a sharp increase since 2010 and marked disparities affecting males, Black individuals, and rural populations.
Alerts clinicians to rising hyperkalemia-related SCD risk in males, Black, and rural patients; leaves open drivers of the post-2010 acceleration.
BACKGROUND: Hyperkalemia is a potentially life-threatening electrolyte disturbance, particularly in older adults with comorbidities. Hyperkalemia can trigger fatal arrhythmias and contribute to sudden cardiac death (SCD). However, national trends in hyperkalemia-related SCD remain poorly defined, especially in the aging US population. METHODS: We conducted a cross-sectional analysis using CDC WONDER mortality data from 1999 to 2020. Deaths were identified using ICD-10 codes for SCD (I46.1, I46.9) as the underlying cause and hyperkalemia (E87.5) as a contributing cause. Age-adjusted mortality rates (AAMRs) were calculated using the 2000 US standard population. Joinpoint regression was used to assess temporal trends and estimate annual percentage changes (APCs). Analyses were stratified by sex, age, race/ethnicity, region, urbanization, and state. RESULTS: Between 1999 and 2020, 36 607 hyperkalemia-related SCD deaths were recorded. The national AAMR more than doubled, from 0.65 to 1.32 per 100 000. Mortality was stable from 1999 to 2009 (APC -1.09%, p = 0.0566) but rose significantly from 2010 to 2020 (APC +5.02%, p < 0.0001). Males, Black individuals, and residents of the South and Midwest had the highest AAMRs and steepest increases. Rural areas consistently showed higher mortality than urban ones. Though most deaths occurred in older adults, significant increases were observed in younger adults (25-44 years) in the last decade. Nevada, Rhode Island, and California had the highest state-level rates. CONCLUSION: Hyperkalemia-related SCD mortality has risen substantially, with marked disparities by sex, race, geography, and age. These trends underscore the need for improved potassium monitoring, risk stratification, and equitable healthcare access to reduce preventable deaths.
No takes yet. Share an insight, caveat, or question.
Hassan et al. (2026) conducted a cross-sectional in Hyperkalemia-related sudden cardiac death (n=36,607). Time period (1999-2020) was evaluated on Annual percentage change (APC) in age-adjusted mortality rate for hyperkalemia-related sudden cardiac death from 2010 to 2020 (APC +5.02%, 95% CI 4.13-5.91, p=<0.0001). The age-adjusted mortality rate for hyperkalemia-related sudden cardiac death more than doubled from 0.65 to 1.32 per 100,000 between 1999 and 2020, rising significantly by 5.02% annually from 2010 to 2020.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Clinical Cardiology